Article
A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
Journal of molecular biology - 23 Aug 2013
Peng Jinyu, Ao Zhujun, Matthews Chris, Wang Xiaoxia, Ramdahin Sue, Chen Xi, Li Junhua, Chen Liyu, He Jianmei, Ball Blake, Fowke Keith, Plummer Frank, Embree Joanne, Yao Xiaojian
Abstract excerpt
The human immunodeficiency virus type 1 (HIV-1) Vif protein counteracts the antiviral activity of the apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3) family of proteins by targeting the proteins for degradation through the ubiquitin-proteasome pathway. Previous mutagenic studies have shown that multiple domains of Vif are required for interacting with APOBEC3G proteins and the...
Topics
- APOBEC-3G Deaminase
- Cytidine Deaminase
- Genetic Variation
- HIV Infections
- HIV Long-Term Survivors
- HIV-1
- Humans
- Kenya
- Mutant Proteins
- Mutation, Missense
